Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, July 10, 2026
🇪🇺 EMA

tarlatamab News

🇪🇺 EMA ← All news

EMA tarlatamab coverage for business development, investment, and market access teams

High impact NewsApr 11, 2026

EMA Backs Amgen's Tarlatamab as First-in-Class BiTE Therapy for Advanced Small Cell Lung Cancer

EMA · oncology · 3 min

Dr. Elena Rossi
High impact NewsApr 11, 2026

EMA Recommends First Bispecific T-Cell Engager for Relapsed Small Cell Lung Cancer

EMA · oncology - small cell lung cancer · 3 min

Dr. Elena Rossi

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.